TrimRx's Blog
Ozempic Type 1 Diabetes — Why It’s Not Approved (2026)
Ozempic isn’t approved for type 1 diabetes because it doesn’t replace insulin — it enhances existing beta-cell function, which type 1 patients lack
Ozempic Obesity — How It Works & What Patients Need to Know
Ozempic (semaglutide) reduces obesity by targeting GLP-1 receptors in the hypothalamus, slowing gastric emptying and suppressing appetite pathways.
Ozempic Type 2 Diabetes — How It Works and What to Expect
Ozempic treats type 2 diabetes by mimicking GLP-1 hormone, reducing blood sugar levels and supporting weight loss. Here’s what patients need to know
Ozempic Prediabetes — FDA Status & Real-World Use
Ozempic isn’t FDA-approved for prediabetes, but off-label use is common. Here’s what the evidence shows about efficacy, safety, and alternatives.
Ozempic Sleep Apnea — Does Semaglutide Improve Breathing?
Semaglutide reduces obstructive sleep apnea severity by 20–30 events per hour through weight loss and airway tissue reduction — clinical evidence and
Ozempic Heart Disease — Protection or Risk? | TrimrX Blog
Ozempic reduces major cardiovascular events by 20% in high-risk patients, but proper monitoring matters. Here’s what the SELECT trial actually shows.
Ozempic NAFLD — What the Clinical Evidence Shows
Ozempic (semaglutide) showed 59% NASH resolution versus 17% placebo in NEJM-published trials — liver fat reduction extends beyond weight loss alone.
Ozempic Insulin Resistance — How GLP-1 Therapy Works
Ozempic improves insulin sensitivity through GLP-1 receptor activation, reducing hepatic glucose output and enhancing peripheral glucose uptake in muscle
Ozempic Cholesterol — Does Semaglutide Lower LDL Levels?
Ozempic (semaglutide) reduces LDL cholesterol by 3–7% and triglycerides by 12–25% through enhanced incretin signaling and reduced hepatic lipid production.
